Pharmaceutical OEM and ODM - Global Market insights and Sales Trends 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Pharmaceutical OEM and ODM - Global Market insights and Sales Trends 2024
Global Pharmaceutical OEM and ODM market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Traditional Chinese Medicine and Western Medicine are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Pharmaceutical OEM and ODM industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Pharmaceutical OEM and ODM key companies include JPS Pharmaceutical, New-In CO., Ltd., Kosei Pharmaceutical Co., Ltd., CD Formulation, DENKEN GROUP, PIM Pharmaceuticals, IL Myeong Pharmaceutical Co., Ltd., Kolmar Korea and Synmosa, etc. JPS Pharmaceutical, New-In CO., Ltd., Kosei Pharmaceutical Co., Ltd. are top 3 players and held % share in total in 2022.
Pharmaceutical OEM and ODM can be divided into Pharmaceutical OEM and Pharmaceutical ODM, etc. Pharmaceutical OEM is the mainstream product in the market, accounting for % share globally in 2022.
Pharmaceutical OEM and ODM is widely used in various fields, such as Traditional Chinese Medicine, Western Medicine, Biologics and Others, etc. Traditional Chinese Medicine provides greatest supports to the Pharmaceutical OEM and ODM industry development. In 2022, global % share of Pharmaceutical OEM and ODM went into Traditional Chinese Medicine filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pharmaceutical OEM and ODM market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
JPS Pharmaceutical
New-In CO., Ltd.
Kosei Pharmaceutical Co., Ltd.
CD Formulation
DENKEN GROUP
PIM Pharmaceuticals
IL Myeong Pharmaceutical Co., Ltd.
Kolmar Korea
Synmosa
Itoh Kanpo Pharmaceutical Co., Ltd.
Hanso Pharmaceutical
Dr.Japan Co., Ltd.
Guangdong Qingyunshan Pharmaceutical Co.,Ltd.
Weidar Chemical & Pharmaceutical Co., Ltd.
Tianjin Hezhi Pharmaceutical Group Co., Ltd.
Segment by Type
Pharmaceutical OEM
Pharmaceutical ODM
Traditional Chinese Medicine
Western Medicine
Biologics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pharmaceutical OEM and ODM market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Pharmaceutical OEM and ODM introduction, etc. Pharmaceutical OEM and ODM Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Pharmaceutical OEM and ODM market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
North America, Europe and Asia Pacific are the key regions for Pharmaceutical OEM and ODM industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Pharmaceutical OEM and ODM key companies include JPS Pharmaceutical, New-In CO., Ltd., Kosei Pharmaceutical Co., Ltd., CD Formulation, DENKEN GROUP, PIM Pharmaceuticals, IL Myeong Pharmaceutical Co., Ltd., Kolmar Korea and Synmosa, etc. JPS Pharmaceutical, New-In CO., Ltd., Kosei Pharmaceutical Co., Ltd. are top 3 players and held % share in total in 2022.
Pharmaceutical OEM and ODM can be divided into Pharmaceutical OEM and Pharmaceutical ODM, etc. Pharmaceutical OEM is the mainstream product in the market, accounting for % share globally in 2022.
Pharmaceutical OEM and ODM is widely used in various fields, such as Traditional Chinese Medicine, Western Medicine, Biologics and Others, etc. Traditional Chinese Medicine provides greatest supports to the Pharmaceutical OEM and ODM industry development. In 2022, global % share of Pharmaceutical OEM and ODM went into Traditional Chinese Medicine filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pharmaceutical OEM and ODM market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
JPS Pharmaceutical
New-In CO., Ltd.
Kosei Pharmaceutical Co., Ltd.
CD Formulation
DENKEN GROUP
PIM Pharmaceuticals
IL Myeong Pharmaceutical Co., Ltd.
Kolmar Korea
Synmosa
Itoh Kanpo Pharmaceutical Co., Ltd.
Hanso Pharmaceutical
Dr.Japan Co., Ltd.
Guangdong Qingyunshan Pharmaceutical Co.,Ltd.
Weidar Chemical & Pharmaceutical Co., Ltd.
Tianjin Hezhi Pharmaceutical Group Co., Ltd.
Segment by Type
Pharmaceutical OEM
Pharmaceutical ODM
Segment by Application
Traditional Chinese Medicine
Western Medicine
Biologics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pharmaceutical OEM and ODM market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Pharmaceutical OEM and ODM introduction, etc. Pharmaceutical OEM and ODM Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Pharmaceutical OEM and ODM market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices